Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.68 -0.08 (-0.68%)
As of: Oct 14, 2026 · 1:27 PM EDT

Ginkgo Bioworks Holdings (DNA) Short-term Investments (2025)

Updated

Ginkgo Bioworks Holdings (DNA) reported Short-term Investments of $255.42 million for Q4 2025.

Analysis

Ginkgo Bioworks Holdings (DNA) Short-term Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.54 Bn 35.24 Bn 1.44 Bn
2 Medpace Holdings 17.33 Bn 15.39 Bn 201.64 Mn
3 Charles River Laboratories International 14.56 Bn 13.76 Bn 363.37 Mn
4 Icon 13.22 Bn 10.33 Bn 479.29 Mn
5 Fortrea Holdings 2.05 Bn 1.42 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 728.68 Mn -33.41 Mn 18.44 Mn
7 Evotec SE 504.32 Mn -1.11 Bn -
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 255.42 Mn
API Access

Ginkgo Bioworks Holdings Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=DNA&period=max&api_key=YOUR_API_KEY